vs
i3 Verticals, Inc.（IIIV）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是i3 Verticals, Inc.的1.4倍（$75.5M vs $52.7M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -14.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $13.8M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -4.7%）
Prusa i3是捷克Prusa Research公司生产的熔融沉积成型3D打印机系列，以Original Prusa i3为注册商标推出，同时也是RepRap项目的组成部分。2016年该系列就被评为全球使用率最高的3D打印机，最早由Josef Průša在2012年完成设计，2015年正式推出商用套件版本，目前最新型号同时提供散件套件和原厂组装版本，具备性价比高、易操作的优势。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
IIIV vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.4倍
$52.7M
营收增速更快
PBYI
高出42.3%
-14.6%
自由现金流更多
PBYI
多$575.0K
$13.8M
两年增速更快
PBYI
近两年复合增速
-4.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $52.7M | $75.5M |
| 净利润 | $484.0K | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 3.1% | 22.7% |
| 净利率 | 0.9% | — |
| 营收同比 | -14.6% | 27.7% |
| 净利润同比 | -76.5% | — |
| 每股收益（稀释后） | $0.02 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IIIVPBYI
| Q4 25 | $52.7M | $75.5M | ||
| Q3 25 | $46.0M | $54.5M | ||
| Q2 25 | $51.9M | $52.4M | ||
| Q1 25 | $63.1M | $46.0M | ||
| Q4 24 | $52.2M | $59.1M | ||
| Q3 24 | $32.0M | $80.5M | ||
| Q2 24 | $46.2M | $47.1M | ||
| Q1 24 | $58.0M | $43.8M |
净利润IIIVPBYI
| Q4 25 | $484.0K | — | ||
| Q3 25 | $3.1M | $8.8M | ||
| Q2 25 | $12.9M | $5.9M | ||
| Q1 25 | $-154.0K | $3.0M | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $117.9M | $20.3M | ||
| Q2 24 | $-7.5M | $-4.5M | ||
| Q1 24 | $1.9M | $-4.8M |
毛利率IIIVPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率IIIVPBYI
| Q4 25 | 3.1% | 22.7% | ||
| Q3 25 | 3.2% | 17.6% | ||
| Q2 25 | -9.3% | 12.7% | ||
| Q1 25 | 8.0% | 8.7% | ||
| Q4 24 | 3.9% | 22.6% | ||
| Q3 24 | 10.6% | 27.4% | ||
| Q2 24 | -2.8% | -4.6% | ||
| Q1 24 | 3.4% | -5.3% |
净利率IIIVPBYI
| Q4 25 | 0.9% | — | ||
| Q3 25 | 6.7% | 16.2% | ||
| Q2 25 | 24.8% | 11.2% | ||
| Q1 25 | -0.2% | 6.5% | ||
| Q4 24 | 3.9% | — | ||
| Q3 24 | 368.2% | 25.2% | ||
| Q2 24 | -16.3% | -9.6% | ||
| Q1 24 | 3.2% | -11.0% |
每股收益（稀释后）IIIVPBYI
| Q4 25 | $0.02 | $0.26 | ||
| Q3 25 | $0.14 | $0.17 | ||
| Q2 25 | $0.50 | $0.12 | ||
| Q1 25 | $0.00 | $0.06 | ||
| Q4 24 | $0.08 | $0.40 | ||
| Q3 24 | $4.93 | $0.41 | ||
| Q2 24 | $-0.32 | $-0.09 | ||
| Q1 24 | $0.08 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.5M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $358.5M | $130.3M |
| 总资产 | $595.9M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资IIIVPBYI
| Q4 25 | $37.5M | $97.5M | ||
| Q3 25 | $66.7M | $94.4M | ||
| Q2 25 | $55.5M | $96.0M | ||
| Q1 25 | $7.7M | $93.2M | ||
| Q4 24 | $85.6M | $101.0M | ||
| Q3 24 | $86.5M | $96.7M | ||
| Q2 24 | $9.7M | $96.8M | ||
| Q1 24 | $3.1M | $107.2M |
总债务IIIVPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | $0 | $34.0M | ||
| Q2 25 | $0 | $45.3M | ||
| Q1 25 | $12.0M | $56.7M | ||
| Q4 24 | $26.2M | $68.0M | ||
| Q3 24 | $26.2M | $79.3M | ||
| Q2 24 | $374.1M | $90.7M | ||
| Q1 24 | $369.6M | $102.0M |
股东权益IIIVPBYI
| Q4 25 | $358.5M | $130.3M | ||
| Q3 25 | $389.6M | $115.3M | ||
| Q2 25 | $383.3M | $104.7M | ||
| Q1 25 | $385.2M | $97.1M | ||
| Q4 24 | $375.0M | $92.1M | ||
| Q3 24 | $379.7M | $71.1M | ||
| Q2 24 | $249.7M | $48.5M | ||
| Q1 24 | $249.3M | $51.0M |
总资产IIIVPBYI
| Q4 25 | $595.9M | $216.3M | ||
| Q3 25 | $638.4M | $202.9M | ||
| Q2 25 | $623.3M | $194.9M | ||
| Q1 25 | $646.4M | $196.2M | ||
| Q4 24 | $726.2M | $213.3M | ||
| Q3 24 | $730.7M | $220.7M | ||
| Q2 24 | $861.7M | $205.0M | ||
| Q1 24 | $625.8M | $214.1M |
负债/权益比IIIVPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | 0.00× | 0.30× | ||
| Q2 25 | 0.00× | 0.43× | ||
| Q1 25 | 0.03× | 0.58× | ||
| Q4 24 | 0.07× | 0.74× | ||
| Q3 24 | 0.07× | 1.12× | ||
| Q2 24 | 1.50× | 1.87× | ||
| Q1 24 | 1.48× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $13.8M | $14.4M |
| 自由现金流率自由现金流/营收 | 26.2% | 19.1% |
| 资本支出强度资本支出/营收 | 0.6% | 0.0% |
| 现金转化率经营现金流/净利润 | 29.18× | — |
| 过去12个月自由现金流最近4个季度 | $6.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流IIIVPBYI
| Q4 25 | $14.1M | $14.4M | ||
| Q3 25 | $14.0M | $9.7M | ||
| Q2 25 | $7.4M | $14.1M | ||
| Q1 25 | $-27.1M | $3.6M | ||
| Q4 24 | $11.5M | $15.6M | ||
| Q3 24 | $15.1M | $11.0M | ||
| Q2 24 | $8.1M | $1.0M | ||
| Q1 24 | $10.7M | $11.2M |
自由现金流IIIVPBYI
| Q4 25 | $13.8M | $14.4M | ||
| Q3 25 | $13.5M | $9.7M | ||
| Q2 25 | $6.8M | $14.1M | ||
| Q1 25 | $-27.6M | $3.6M | ||
| Q4 24 | $11.0M | $15.6M | ||
| Q3 24 | $14.6M | $11.0M | ||
| Q2 24 | $7.2M | $1.0M | ||
| Q1 24 | $9.9M | — |
自由现金流率IIIVPBYI
| Q4 25 | 26.2% | 19.1% | ||
| Q3 25 | 29.5% | 17.7% | ||
| Q2 25 | 13.1% | 26.8% | ||
| Q1 25 | -43.8% | 7.7% | ||
| Q4 24 | 21.1% | 26.4% | ||
| Q3 24 | 45.6% | 13.7% | ||
| Q2 24 | 15.6% | 2.1% | ||
| Q1 24 | 17.1% | — |
资本支出强度IIIVPBYI
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 0.9% | 0.0% | ||
| Q2 25 | 1.0% | 0.0% | ||
| Q1 25 | 0.8% | 0.1% | ||
| Q4 24 | 0.9% | 0.0% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 1.9% | 0.0% | ||
| Q1 24 | 1.4% | 0.0% |
现金转化率IIIVPBYI
| Q4 25 | 29.18× | — | ||
| Q3 25 | 4.52× | 1.10× | ||
| Q2 25 | 0.57× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 5.59× | — | ||
| Q3 24 | 0.13× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.72× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IIIV
| License And Service | $35.7M | 68% |
| Proprietary Payments Revenue | $14.5M | 27% |
| Other Revenue | $2.5M | 5% |
PBYI
暂无分部数据
